Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Category
1.1.2. End-Use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1:
1.9.2. Objective 2:
1.9.3. Objective 3:
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitve Landscape Snapshot
Chapter 3. Manual Wheelchairs Market Variables, Trends & Scope
3.1. Market Dynamics
3.1.1. Market driver analysis
3.1.2. Market restraint analysis
3.2. Manual wheelchairs market Analysis Tools
3.2.1. Industry Analysis – Porter’s
3.2.2. PESTEL Analysis
Chapter 4. Manual Wheelchairs Market: Category Estimates & Trend Analysis
4.1. Manual Wheelchairs: Category market Share Analysis, 2022 & 2030
4.2. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.2.1. Adult
4.2.2. Pediatric
Chapter 5. Manual Wheelchairs Market: End-Use Estimates & Trend Analysis
5.1. Manual Wheelchairs: End-Use market Share Analysis, 2022 & 2030
5.2. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.2.1. Hospitals
5.2.2. Outpatient Facilities
5.2.3. Homecare
Chapter 6. Manual Wheelchairs Market: Regional Estimates & Trend Analysis
6.1. Regional Market Snapshot
6.2. North America
6.2.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.3. Europe
6.3.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.3.2. UK
6.3.2.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.3.4. France
6.3.4.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.4.3. China
6.4.3.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.4.4. India
6.4.4.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.4.5. Australia
6.4.5.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.4.6. South Korea
6.4.6.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.5. Latin America
6.5.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.5.4. Argentina
6.5.4.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.6. MEA
6.6.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.6.4. UAE
6.6.4.1. Market estimates and forecast, 2018 – 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.1.1. Carex Health Brands, Inc.
7.1.1.1. Company overview
7.1.1.2. Financial performance
7.1.1.3. Product benchmarking
7.1.1.4. Strategic initiatives
7.1.2. Drive Medical Design & Manufacturing
7.1.2.1. Company overview
7.1.2.2. Financial performance
7.1.2.3. Product benchmarking
7.1.2.4. Strategic initiatives
7.1.3. Graham-Field Health Products Inc.
7.1.3.1. Company overview
7.1.3.2. Financial performance
7.1.3.3. Product benchmarking
7.1.3.4. Strategic initiatives
7.1.4. Invacare
7.1.4.1. Company overview
7.1.4.2. Financial performance
7.1.4.3. Product benchmarking
7.1.4.4. Strategic initiatives
7.1.5. Medline
7.1.5.1. Company overview
7.1.5.2. Financial performance
7.1.5.3. Product benchmarking
7.1.5.4. Strategic initiatives
7.1.6. Sunrise Medical LLC
7.1.6.1. Company overview
7.1.6.2. Financial performance
7.1.6.3. Product benchmarking
7.1.6.4. Strategic initiatives
7.1.7. Karman Healthcare
7.1.7.1. Company overview
7.1.7.2. Financial performance
7.1.7.3. Product benchmarking
7.1.7.4. Strategic initiatives
7.1.8. Quantum Rehab
7.1.8.1. Company overview
7.1.8.2. Financial performance
7.1.8.3. Product benchmarking
7.1.8.4. Strategic initiatives
7.1.9. Numotion
7.1.9.1. Company overview
7.1.9.2. Financial performance
7.1.9.3. Product benchmarking
7.1.9.4. Strategic initiatives
7.1.10. Pride Mobility Products Corp.
7.1.10.1. Company overview
7.1.10.2. Financial performance
7.1.10.3. Product benchmarking
7.1.10.4. Strategic initiatives
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer